A Requirement for Metamorphic Interconversion in the Antimicrobial Activity of Chemokine XCL1.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Biochemistry

• Publication date

  2016-06-28

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/acs.biochem.6b00353PMID 27305837PMCID PMC6956654
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CXCL14 Displays Antimicrobial Activity against Respiratory Tract Bacteria and Contributes to Clearance of Streptococcus pneumoniae Pulmonary Infection

  2015cited by this paper
• Engineering Metamorphic Chemokine Lymphotactin/XCL1 into the GAG-Binding, HIV-Inhibitory Dimer Conformation.

  2015cited by this paper
• Structural Determinants for the Selective Anti-HIV-1 Activity of the All-β Alternative Conformer of XCL1

  2015cited by this paper
• Hydrophobic Determinants of α-Defensin Bactericidal Activity

  2014cited by this paper
• Human defensins facilitate local unfolding of thermodynamically unstable regions of bacterial protein toxins.

  2014cited by this paper
• A high‐throughput screen for antibiotic drug discovery

  2014cited by this paper
• The dynamic action mechanism of small cationic antimicrobial peptides.

  2014cited by this paper
• Chemokine (C-X-C Motif) Receptor 4 and Atypical Chemokine Receptor 3 Regulate Vascular α1-Adrenergic Receptor Function

  2014cited by this paper
• Antibiotic resistance: The last resort

  2013cited by this paper
• Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistance

  2013cited by this paper
• Antimicrobial Peptides Design by Evolutionary Multiobjective Optimization

  2013cited by this paper
• Strategies to Minimize Antibiotic Resistance

  2013cited by this paper
• The CD8-Derived Chemokine XCL1/Lymphotactin Is a Conformation-Dependent, Broad-Spectrum Inhibitor of HIV-1

  2013cited by this paper
• Antibiotics in the clinical pipeline in 2013

  2013cited by this paper
• Peptide design for antimicrobial and immunomodulatory applications.

  2013cited by this paper
• Structural perspectives on antimicrobial chemokines

  2012cited by this paper
• Antimicrobial Activities of Chemokines: Not Just a Side-Effect?

  2012cited by this paper
• Antimicrobial Chemokines

  2012cited by this paper
• Rhesus Macaque Theta Defensins Suppress Inflammatory Cytokines and Enhance Survival in Mouse Models of Bacteremic Sepsis

  2012cited by this paper
• CXCL17 Is a Mucosal Chemokine Elevated in Idiopathic Pulmonary Fibrosis That Exhibits Broad Antimicrobial Activity

  2012cited by this paper
• Systematic classification of vertebrate chemokines based on conserved synteny and evolutionary history

  2012cited by this paper
• A Locked, Dimeric CXCL12 Variant Effectively Inhibits Pulmonary Metastasis of CXCR4-Expressing Melanoma Cells Due to Enhanced Serum Stability

  2012cited by this paper
• Criterion for amino acid composition of defensins and antimicrobial peptides based on geometry of membrane destabilization.

  2011cited by this paper
• Antimicrobial Peptides: Successes, Challenges and Unanswered Questions

  2011cited by this paper
• Human defensin 5 disulfide array mutants: disulfide bond deletion attenuates antibacterial activity against Staphylococcus aureus.

  2011cited by this paper
• Chemokines in health and disease.

  2011cited by this paper
• Targeting SDF-1/CXCL12 with a ligand that prevents activation of CXCR4 through structure-based drug design.

  2010cited by this paper
• Anionic Amino Acids near the Pro-α-defensin N Terminus Mediate Inhibition of Bactericidal Activity in Mouse Pro-cryptdin-4*

  2009cited by this paper
• Estimating maximum likelihood phylogenies with PhyML.

  2009cited by this paper
• Monomeric structure of the cardioprotective chemokine SDF‐1/CXCL12

  2009cited by this paper
• The antimicrobial activity of CCL28 is dependent on C‐terminal positively‐charged amino acids

  2009cited by this paper
• Interconversion between two unrelated protein folds in the lymphotactin native state

  2008cited by this paper
• PROMALS3D web server for accurate multiple protein sequence and structure alignments

  2008cited by this paper
• Mechanisms of alpha-defensin bactericidal action: comparative membrane disruption by Cryptdin-4 and its disulfide-null analogue.

  2008cited by this paper
• PROMALS3D: a tool for multiple protein sequence and structure alignments

  2008cited by this paper
• An engineered second disulfide bond restricts lymphotactin/XCL1 to a chemokine-like conformation with XCR1 agonist activity.

  2007cited by this paper
• Chemokine: receptor structure, interactions, and antagonism.

  2007cited by this paper
• Matrix metalloproteinase-7 activation of mouse paneth cell pro-alpha-defensins: SER43 down arrow ILE44 proteolysis enables membrane-disruptive activity.

  2006cited by this paper
• The chemokine and chemokine receptor superfamilies and their molecular evolution

  2006cited by this paper
• Matrix Metalloproteinase-7 Activation of Mouse Paneth Cell Pro-α-defensins

  2006cited by this paper
• A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood.

  2003cited by this paper
• Many chemokines including CCL20/MIP-3alpha display antimicrobial activity.

  2003cited by this paper
• Many chemokines including CCL20/MIP‐3α display antimicrobial activity

  2003cited by this paper
• Mammalian defensins in immunity: more than just microbicidal.

  2002cited by this paper
• Structural Rearrangement of Human Lymphotactin, a C Chemokine, under Physiological Solution Conditions*

  2002cited by this paper
• Staphylococcal superantigens induce lymphotactin production by human CD4+ and CD8+ T cells.

  2001cited by this paper
• Cutting Edge: IFN-Inducible ELR− CXC Chemokines Display Defensin-Like Antimicrobial Activity1

  2001cited by this paper
• β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6

  1999cited by this paper
• Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6.

  1999cited by this paper
• Designer assays for antimicrobial peptides. Disputing the "one-size-fits-all" theory.

  1997cited by this paper
• Designer Assays for Antimicrobial Peptides

  1997cited by this paper
• Structure and expression of two highly related genes encoding SCM‐1/human lymphotactin

  1996cited by this paper
• Structure, function, and membrane integration of defensins.

  1995cited by this paper
• Interactions between human defensins and lipid bilayers: Evidence for formation of multimeric pores

  1994cited by this paper
• Monocyte-chemotactic activity of defensins from human neutrophils.

  1989cited by this paper
• Concurrent assessment of inner and outer membrane permeabilization and bacteriolysis in E. coli by multiple-wavelength spectrophotometry.

  1988cited by this paper

• Recent mechanistic insights into conformational interconversion in metamorphic proteins.

  2026cites this paper
• The multifaceted role of XCL1 in health and disease

  2025cites this paper
• XCL1: a multifunctional chemokine with metamorphic properties and therapeutic potential after injury to the nervous system - review.

  2025cites this paper
• Fold-switching proteins

  2025cites this paper
• The Role of Chemokines in Obesity and Exercise-Induced Weight Loss

  2024cites this paper
• Design and discovery of metamorphic proteins

  2022cites this paper
• Morbid Obesity in Women Is Associated with an Altered Intestinal Expression of Genes Related to Cancer Risk and Immune, Defensive, and Antimicrobial Response

  2022cites this paper
• NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications

  2021cites this paper
• Metamorphic Protein Folding Encodes Multiple Anti-Candida Mechanisms in XCL1

  2021cites this paper
• Evolution of fold switching in a metamorphic protein

  2020cites this paper
• Switchable Membrane Remodeling and Antifungal Defense by Metamorphic Chemokine XCL1

  2020cites this paper
• Chemokine CCL28 Is a Potent Therapeutic Agent for Oropharyngeal Candidiasis

  2020cites this paper
• Plant Defensins from a Structural Perspective

  2020cites this paper
• Specific binding‐induced modulation of the XCL1 metamorphic equilibrium

  2020cites this paper
• Unfolding the Mysteries of Protein Metamorphosis

  2018cites this paper
• Clinical importance of chemokines and inflammatory cytokines for patient care following percutaneous nephrolithotripsy.

  2017cites this paper
• Characterization of Antimicrobial and Host-Defense Peptides by NMR Spectroscopy

  2017cites this paper
• Complement factor P is a ligand for the natural killer cell–activating receptor NKp46

  2017cites this paper
• Complement factor P: promoting the antibacterial activity of natural killer cells

  2017cites this paper